Skip to content

Usefulness of LRG for predicting the activity of inflammatory bowel disease

Usefulness of LRG for predicting the activity of inflammatory bowel disease - Usefulness of LRG for predicting IBD activity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043826
Enrollment
100
Registered
2021-04-03
Start date
2020-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease

Interventions

None listed

Sponsors

Nagoya University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with inflammatory bowel disease

Exclusion criteria

Exclusion criteria: Patients under 15 years Contraindicated patients for endoscopy Patients with autoimmune diseases other than inflammatory bowel disease Patients that the doctor deems inappropriate

Design outcomes

Primary

MeasureTime frame
Whether LRG can predict IBD activity

Secondary

MeasureTime frame
Whether LRG can predict the therapeutic effect and prognosis of IBD

Countries

Japan

Contacts

Public ContactTatsuya Kawamura

Nagoya University Hospital Department of Gastroenterology and Hepatology

t-kawa@med.nagoya-u.ac.jp052-741-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026